Literature DB >> 22915354

Drug safety studies and measures of effect using the self-controlled case series design.

Kumanan Wilson1, Steven Hawken.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22915354     DOI： 10.1002/pds.3337

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN： 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  3 in total

1.  Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.

Authors:  Julia Hippisley-Cox; Martina Patone; Xue W Mei; Defne Saatci; Sharon Dixon; Kamlesh Khunti; Francesco Zaccardi; Peter Watkinson; Manu Shankar-Hari; James Doidge; David A Harrison; Simon J Griffin; Aziz Sheikh; Carol A C Coupland
Journal:  BMJ       Date:  2021-08-26

2.  Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries.

Authors:  Jacob Dag Berild; Vilde Bergstad Larsen; Emilia Myrup Thiesson; Toni Lehtonen; Mari Grøsland; Jon Helgeland; Jan Wolhlfahrt; Jørgen Vinsløv Hansen; Arto A Palmu; Anders Hviid
Journal:  JAMA Netw Open       Date:  2022-06-01

3.  Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.

Authors:  Marco Massari; Stefania Spila Alegiani; Cristina Morciano; Matteo Spuri; Pasquale Marchione; Patrizia Felicetti; Valeria Belleudi; Francesca Romana Poggi; Marco Lazzeretti; Michele Ercolanoni; Elena Clagnan; Emanuela Bovo; Gianluca Trifirò; Ugo Moretti; Giuseppe Monaco; Olivia Leoni; Roberto Da Cas; Fiorella Petronzelli; Loriana Tartaglia; Nadia Mores; Giovanna Zanoni; Paola Rossi; Sarah Samez; Cristina Zappetti; Anna Rosa Marra; Francesca Menniti Ippolito
Journal:  PLoS Med       Date:  2022-07-28       Impact factor: 11.613
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.